Compile Data Set for Download or QSAR
maximum 50k data
Found 298 Enz. Inhib. hit(s) with all data for entry = 6686
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146964(US8957074, 3)
Affinity DataIC50:  1nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146997(US8957074, 36)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147014(US8957074, 53)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147015(US8957074, 54)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147027(US8957074, 67)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147041(US8957074, 83)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147049(US8957074, 89)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147083(US8957074, 123)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146965(US8957074, 4)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146970(US8957074, 9)
Affinity DataIC50: <4nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147042(US8957074, 82)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147091(US8957074, 131)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146963(US8957074, 2)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146971(US8957074, 10)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM47154(US8957074, 81)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147044(US8957074, 84 | US8957074, 86)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147047(US8957074, 87)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147048(US8957074, 88)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147050(US8957074, 90)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147053(US8957074, 93)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147087(US8957074, 127)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147093(US8957074, 133)
Affinity DataIC50: <5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146998(US8957074, 37)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147026(US8957074, 66)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147100(US8957074, 140)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147044(US8957074, 84 | US8957074, 86)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147031(US8957074, 71)
Affinity DataIC50:  5.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146974(US8957074, 13)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147045(US8957074, 85)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147051(US8957074, 91)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147052(US8957074, 92)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147028(US8957074, 68)
Affinity DataIC50:  6.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146980(US8957074, 19)
Affinity DataIC50:  6.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147055(US8957074, 95)
Affinity DataIC50:  7nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147095(US8957074, 135)
Affinity DataIC50:  7nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147082(US8957074, 122 | US8957074, 124)
Affinity DataIC50:  7.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146986(US8957074, 25)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147020(US8957074, 59)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147070(US8957074, 110)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147077(US8957074, 117)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147094(US8957074, 134)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146972(US8957074, 11)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147067(US8957074, 107)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147088(US8957074, 128)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147090(US8957074, 130)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147078(US8957074, 118)
Affinity DataIC50:  9.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147023(US8957074, 62)
Affinity DataIC50:  10nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147029(US8957074, 69)
Affinity DataIC50:  11.5nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM146966(US8957074, 5)
Affinity DataIC50:  12nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM147065(US8957074, 105)
Affinity DataIC50:  12nMpH: 7.5 T: 2°CAssay Description:An assay for monitoring CDK4/cyclin D1-catalyzed phosphorylation of pRb at the Ser780 site was performed using TR-FRET in a 384-well format, and was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 298 total ) | Next | Last >>
Jump to: